Related by context. Frequent words. (Click for all words.) 64 refractory chronic lymphocytic 62 Diabetic Macular Edema 62 Daclizumab 62 relapsing multiple sclerosis 62 Pirfenidone 61 AAT deficiency 61 neovascular age 61 Idiopathic Pulmonary Fibrosis 61 post herpetic neuralgia PHN 61 Etanercept 61 Irinotecan 61 Community Acquired Pneumonia 60 Initiate Phase 60 MPS VI 60 oropharyngeal candidiasis 60 pancreatic insufficiency 60 Orphan Drug Status 60 Tacrolimus 59 AA amyloidosis 59 Epratuzumab 59 ACZ# 59 orphan medicinal product 59 paroxysmal nocturnal hemoglobinuria PNH 59 Alemtuzumab 59 Icatibant 59 nosocomial pneumonia 58 Ischemic 58 Factor VIIa 58 idiopathic pulmonary fibrosis IPF 58 Pulmonary Arterial Hypertension 58 retinal vein occlusion 58 multiple myeloma MM 58 Mipomersen 58 Recombinant Human 58 Nexavar ® 58 Allergic Rhinitis 58 Gefitinib 58 recurrent glioblastoma 58 Pivotal Phase III 58 orphan designation 58 Dasatinib 58 NYHA Class II 58 Lenalidomide 58 Vandetanib 58 Hemophilia B 58 FDA Orphan Drug 58 Wet AMD 58 PsA 58 Systemic Lupus Erythematosus 58 Single Dose 58 pulmonary arterial hypertension PAH 57 neurogenic orthostatic hypotension 57 non alcoholic steatohepatitis 57 Gaucher Disease 57 Aliskiren 57 chronic HBV infection 57 rilonacept 57 diabetic macular edema 57 injectable formulation 57 Pivotal Trial 57 Kuvan R 57 liposomal formulation 57 Orphan Medicinal Product 57 diabetic neuropathic pain 57 colorectal carcinoma 57 pancreatic NET 57 leukemia CLL 57 Pulmonary hypertension 57 Amrubicin 57 gastrointestinal stromal tumors GIST 57 proteasome inhibitor 57 paroxysmal nocturnal hemoglobinuria 57 Argatroban 57 Completes Enrollment 57 Azilect ® 57 Ixempra 57 amrubicin 57 Orphan Drug status 57 acute promyelocytic leukemia 57 GI GVHD 57 Panzem R 57 blood clotting disorder 57 hepatitis C HCV 57 Irritable Bowel Syndrome IBS 57 Laquinimod 56 Chronic Lymphocytic Leukemia 56 Natalizumab 56 Torisel 56 Glioma 56 actinic keratosis 56 immuno inflammatory diseases 56 Presents Positive 56 cell acute lymphoblastic 56 carcinoid syndrome 56 Ulcerative colitis 56 Nimotuzumab 56 carcinoid tumors 56 relapsed multiple myeloma 56 FDA Accepts 56 TYGACIL 56 Pivotal Phase